Tag: MArket Access

If your company is developing a new medicine and you’re looking at France as part of your European launch, you might wonder:👉 “Is it possible for patients in France to access our drug before we get full marketing authorisation?” The good news: yes, it is possible — thanks to two special early access pathways. These…